TKPHF:OTCMKTS
Takeda Pharmaceutical Co Ltd
US$ 33.85
0.00%
(0.00) Siku 1
6 Okt, 11:51:40 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya TKPHF...
Mtaji wa soko
59.62B
Wastani wa kiasi cha mauzo
elfu 2.49
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$ 39.20
Chini kwa wiki 52
US$ 26.33
Beta
-2.60
Hisa za wawekezaji
1.60B
Idadi ya wafanyakazi
elfu 47
Mtaji wa soko
59.62B
Wastani wa kiasi cha mauzo
elfu 2.49
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$ 39.20
Chini kwa wiki 52
US$ 26.33
Beta
-2.60
Hisa za wawekezaji
1.60B
Idadi ya wafanyakazi
elfu 47
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 6 zilizopita
Takeda stock pre-market at EUR 16.55
Wasifu
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
Kuhusu Takeda Pharmaceutical Co Ltd
Afisa Mkuu Mtendaji (CEO)Christophe Weber | Christophe Weber
Wafanyakazielfu 47
Lilianzishwa12 Jun 1781
Makao makuu-
Sekta-
Tovutitakeda.com